IQOS ILUMA Series Dedicated Tobacco Stick "SENTIA" Launches "Sentia Cobalt Blue" Sequentially from July 6, 2026 (Mon)

Philip Morris Japan LLC (Headquarters: Chiyoda-ku, Tokyo, President: Kostas Salvaras, hereinafter "PMJ") will launch "Sentia Cobalt Blue" from the IQOS ILUMA series dedicated tobacco stick "SENTIA" sequentially from July 6, 2026 (Mon) at four IQOS stores nationwide*1, IQOS shops (some Yamada Denki and Bic Camera stores, etc.)*1*2, IQOS corners (some Don Quijote group stores, etc.)*1*2, and tobacco retailers nationwide, including convenience stores*2. Sales will begin on the IQOS online store from July 8, 2026 (Wed).

With the launch of "Sentia Cobalt Blue," the "SENTIA" product lineup will expand to a total of 19 varieties.

PMJ will continue to strive to provide products and services that satisfy adult smokers aged 20 and over, aiming to realize a "smoke-free society."

*1 As of July 2026.

*2 Delivery dates and launch start dates may vary by store.

SENTIA New Product Information

The "SENTIA" to be launched this time is as follows:

Other "SENTIA" Lineup

The 18 existing "SENTIA" varieties are as follows:

PMI's Corporate Vision: A Global Leader in a Smoke-Free Society

Philip Morris International (hereinafter "PMI") is an international consumer goods company committed to realizing a "smoke-free society" and evolving its portfolio to include products beyond combustible cigarettes and nicotine in the long term. The current product portfolio primarily consists of combustible cigarettes and smoke-free tobacco or nicotine-containing products (hereinafter "smoke-free products"). PMI's smoke-free products are available in major cities or nationwide in over 105 markets globally, and it is estimated that as of December 31, 2025, more than 43 million adult smokers worldwide (20 years of age or older in Japan, hereinafter the same) use PMI's smoke-free products. The smoke-free products business accounted for 43% of net revenues in PMI's first quarter of 2026. Since 2008, PMI has invested US$16 billion to develop, scientifically substantiate, and commercialize innovative smoke-free products for adult smokers who would otherwise continue to smoke, with the goal of phasing out combustible cigarettes. This includes building world-class scientific assessment capabilities, particularly in the areas of preclinical systems toxicology, clinical and behavioral research, and post-market surveillance. Following rigorous scientific review, the U.S. Food and Drug Administration (FDA) has authorized the marketing of Swedish Match's General snus and ZYN oral nicotine pouches, as well as some of PMI's IQOS devices and tobacco sticks. These were the first authorizations in their respective categories. Furthermore, some IQOS devices and tobacco sticks, as well as General snus, have received FDA authorization as Modified Risk Tobacco Products (MRTPs). With a strong foundation and significant expertise in life sciences, PMI has a long-term goal of expanding into the wellness sector, aiming to enrich lives by providing a seamless health experience.

For more information, please visit the PMI website (www.pmi.com) and PMI Science (www.pmiscience.com).

About PMJ's Commitment to a Smoke-Free Society

Philip Morris Japan (PMJ) is a subsidiary of PMI in Japan. It conducts marketing and sales promotion activities for PMI products sold in Japan. Since starting operations in Japan in 1985, PMJ has continued to expand its business and grow, employing approximately 1,600 people nationwide and leading the market, primarily in heated tobacco, with a 45% share of the Japanese tobacco market (as of Q1 2026 financial results). PMJ is driving PMI's efforts to achieve a "smoke-free society" here in Japan. For more details on PMJ's initiatives to expand "smoke-free" facilities and tourist destinations nationwide, where only heated tobacco can be used, in pursuit of a "smoke-free society," please visit the PMJ website: https://www.pmi.com/markets/japan/ja/home